Mathias Rummel
Impact in
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 81
- Genetics 63
- Chronic Lymphocytic Leukemia Research 60
- Co-authors
- Dieter Hoelzer (15 shared papers)Bruce D. Cheson (2 shared papers)Eckhart Weidmann (19 shared papers)Dorothea Kofahl-Krause (13 shared papers)Wolfram Brugger (17 shared papers)Paris S. Mitrou (15 shared papers)Juergen Barth (14 shared papers)Ulrich Kaiser (14 shared papers)
- Journals
- Blood (36 papers)Journal of Clinical Oncology (21 papers)Seminars in Oncology (4 papers)British Journal of Haematology (3 papers)Hematological Oncology (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Mathias Rummel
125 papers receiving 5.1k citations
Mathias Rummel's Hit Papers
Peers
Comparison fields: 5 of 91
- Genetics 2.0k
- Pathology and Forensic Medicine 3.0k
- Hematology 1.6k
- Oncology 1.7k
- Neurology 470
Countries citing papers authored by Mathias Rummel
This map shows the geographic impact of Mathias Rummel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Rummel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Rummel more than expected).
Fields of papers citing papers by Mathias Rummel
This network shows the impact of papers produced by Mathias Rummel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Rummel. The network helps show where Mathias Rummel may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathias Rummel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial Hit paper breakdown → | 2013 | 1013 |
| 2 | 2005 | 339 | |
| 3 | 2010 | 334 | |
| 4 | 2009 | 332 | |
| 5 | 2010 | 315 | |
| 6 | 2013 | 209 | |
| 7 | 2009 | 192 | |
| 8 | 2004 | 158 | |
| 9 | Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases. | 2002 | 155 |
| 10 | 2011 | 136 | |
| 11 | 2016 | 124 | |
| 12 | 2009 | 116 | |
| 13 | 2015 | 115 | |
| 14 | 2010 | 112 | |
| 15 | 2016 | 107 | |
| 16 | 2010 | 73 | |
| 17 | 2012 | 65 | |
| 18 | 2002 | 63 | |
| 19 | 2007 | 55 | |
| 20 | 2016 | 53 |
About Mathias Rummel
Mathias Rummel is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Pulmonary and Respiratory Medicine, having authored 129 papers that have together received 5.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (81 papers), Chronic Lymphocytic Leukemia Research (60 papers), Platelet Disorders and Treatments (16 papers), Viral-associated cancers and disorders (14 papers), Acute Lymphoblastic Leukemia research (10 papers), Blood groups and transfusion (9 papers), CAR-T cell therapy research (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Genetics (2.0k citations), Pathology and Forensic Medicine (3.0k citations), Hematology (1.6k citations), Oncology (1.7k citations) and Neurology (470 citations). Mathias Rummel has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Dieter Hoelzer, Bruce D. Cheson, Eckhart Weidmann, Dorothea Kofahl-Krause, Wolfram Brugger, Paris S. Mitrou, Juergen Barth, Ulrich Kaiser, Manfred Welslau and Ulrich von Grünhagen. Their work appears in journals such as Blood, Journal of Clinical Oncology, Seminars in Oncology, British Journal of Haematology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.